STEPHANIE HUTCHINSON: Open Payments
NPI 1154640357 · BARBOURVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$871 in 65 payments from 15 companies in 2025. Trend: 2023 $1,606 · 2024 $1,226 · 2025 $871
Food & beverage: $871
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 18 | $180 |
| Novo Nordisk Inc | 15 | $165 |
| Vanda Pharmaceuticals Inc. | 11 | $160 |
| Collegium Pharmaceutical, Inc. | 4 | $79 |
| Phathom Pharmaceuticals, Inc. | 4 | $57 |
| ABBVIE INC. | 2 | $38 |
| Amgen Inc. | 2 | $38 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $38 |
| Viatris Specialty LLC | 1 | $21 |
| Janssen Biotech, Inc. | 1 | $17 |
Products named: REXULTI, FANAPT, Rybelsus, Jornay PM, VOQUEZNA, Ozempic, Kerendia, QULIPTA.
Industry payments across KY — which companies pay providers there.
